PEP
39
-9
SWK
50
-5
DAL
84
-3
STT
64
2
DG
8
-2
JNPR
50
-6
STZ
52
-6
HCA
48
-2
BMY
55
-8
UPS
48
2
ALLE
37
-4
M
31
-3
DVN
14
-6
DLTR
38
-4
ACN
47
-5
NOV
52
-5
MNST
45
-21
MAS
52
-4
HSIC
45
5
PEG
62
4
PEP
39
-9
SWK
50
-5
DAL
84
-3
STT
64
2
DG
8
-2
JNPR
50
-6
STZ
52
-6
HCA
48
-2
BMY
55
-8
UPS
48
2
ALLE
37
-4
M
31
-3
DVN
14
-6
DLTR
38
-4
ACN
47
-5
NOV
52
-5
MNST
45
-21
MAS
52
-4
HSIC
45
5
PEG
62
4
Financhill
Back

Erdene Resource Development Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

ERD.TO
Erdene Resource Development

Last Price:
0.61
Seasonality Move:
25.94%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
33
Erdene Resource Development (ERD.TO) is a Sell

Is Erdene Resource Development a Buy, Sell or Hold?

  • The current Erdene Resource Development [ERD.TO] share price is $0.61. The Score for ERD.TO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ERD.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ERD.TO Stock Price Chart

What is Erdene Resource Development's stock price today?

  • The Erdene Resource Development share price today is $0.61
    The current trend is relatively stagnant and ERD.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ERD.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.15 Sell
Chaikin Money Flow: 124368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.64) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ERD.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.6 Buy
20-day SMA: 0.64 Sell
50-day SMA: 0.61 Sell
200-day SMA: 0.46 Buy
8-day EMA: 0.6 Buy
20-day EMA: 0.63 Sell
50-day EMA: 0.6 Buy
200-day EMA: 0.48 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Erdene Resource Development Earnings Growth & ERD.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Erdene Resource Development Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):